» Articles » PMID: 10785214

Distinction Between Early and Late Ovarian Hyperstimulation Syndrome

Overview
Journal Fertil Steril
Date 2000 Apr 28
PMID 10785214
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare patient and cycle characteristics among three study groups: early ovarian hyperstimulation syndrome (OHSS), late OHSS, and non-OHSS.

Design: Prospective observational study.

Setting: University assisted conception service.

Patient(s): Women undergoing in vitro fertilization, intracytoplasmic sperm injection or gamete intrafallopian transfer treatment at Bristol University In Vitro Fertilization Service between January 1, 1995, and December 31, 1998.

Intervention: None.

Main Outcome Measure(s): Patient age, prevalence of polycystic ovaries, gonadotropin requirement, peak serum estradiol (E(2)) concentration, number of oocytes retrieved, clinical pregnancy rate, number of gestation sacs, and severity of OHSS.

Result(s): Women with early OHSS had significantly higher serum E(2) levels and lower gonadotropin requirements than did the other groups. Cycles with either early or late OHSS had significantly more oocytes collected than those without OHSS. Serum E(2) and oocyte numbers did not accurately predict the risk of developing late OHSS. Clinical pregnancies occurred in all cycles with late OHSS, and multiple pregnancies were significantly more frequent in the late OHSS group than in the other groups. Late OHSS was more likely than early OHSS to be severe.

Conclusion(s): Early OHSS relates to "excessive" preovulatory response to stimulation, whereas late OHSS depends on the occurrence of pregnancy, is likelier to be severe, and is only poorly related to preovulatory events.

Citing Articles

The Incidence of Moderate and Severe Ovarian Hyperstimulation Syndrome in Hospitalized Patients in China.

Zheng D, Shi Y, Wang Y, Li R, Long X, Qiao J Health Data Sci. 2024; 3:0009.

PMID: 38487201 PMC: 10880172. DOI: 10.34133/hds.0009.


Age at menarche and risk of ovarian hyperstimulation syndrome in women undergoing IVF/ICSI cycles: a retrospective cohort study.

Wang Q, Tang X, Lv X, Meng X, Geng L, Zhong Z BMJ Open. 2024; 14(2):e076867.

PMID: 38365296 PMC: 10875511. DOI: 10.1136/bmjopen-2023-076867.


Beyond the Umbrella: A Systematic Review of the Interventions for the Prevention of and Reduction in the Incidence and Severity of Ovarian Hyperstimulation Syndrome in Patients Who Undergo In Vitro Fertilization Treatments.

Palomba S, Costanzi F, Nelson S, Besharat A, Caserta D, Humaidan P Int J Mol Sci. 2023; 24(18).

PMID: 37762488 PMC: 10531768. DOI: 10.3390/ijms241814185.


Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: a systematic umbrella review of the best clinical evidence.

Palomba S, Costanzi F, Nelson S, Caserta D, Humaidan P Reprod Biol Endocrinol. 2023; 21(1):67.

PMID: 37480081 PMC: 10360244. DOI: 10.1186/s12958-023-01113-6.


Spontaneous and iatrogenic ovarian hyperstimulation syndrome in the absence of FSHR mutations: a case report of two unexpected cases.

Daolio J, Sperduti S, Casarini L, Falbo A, Materazzo C, Aguzzoli L BMC Med Genomics. 2023; 16(1):45.

PMID: 36882810 PMC: 9990314. DOI: 10.1186/s12920-023-01473-3.